Citadel Advisors’s Danimer Scientific, Inc. DNMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,417
Closed -$25.8K 15705
2024
Q3
$25.8K Buy
1,417
+1,134
+401% +$19.8K ﹤0.01% 12574
2024
Q2
$6.82K Buy
283
+221
+356% +$6.87K ﹤0.01% 13300
2024
Q1
$2.7K Buy
62
+48
+343% +$1.99K ﹤0.01% 13979
2023
Q4
$588 Buy
+14
New +$761 ﹤0.01% 13994
2023
Q3
Sell
-2,220
Closed -$201K 15329
2023
Q2
$211K Buy
2,220
+2,167
+4,089% +$278K ﹤0.01% 9754
2023
Q1
$7.29K Sell
53
-3,235
-98% -$296K ﹤0.01% 13741
2022
Q4
$235K Buy
+3,288
New +$311K ﹤0.01% 9810
2022
Q2
Sell
-2,120
Closed -$385K 14369
2022
Q1
$497K Sell
2,120
-3,108
-59% -$627K ﹤0.01% 9417
2021
Q4
$1.78M Sell
5,228
-6,266
-55% -$3.45M ﹤0.01% 6512
2021
Q3
$7.51M Buy
11,494
+7,823
+213% +$5.75M ﹤0.01% 3561
2021
Q2
$3.68M Buy
+3,671
New +$3.66M ﹤0.01% 5128

Other funds holding DNMR

Citadel Advisors's DNMR Position: Q4 2024 in Review

Citadel Advisors sold out of Danimer Scientific, Inc. (DNMR) in Q4 2024, closing a stake of 1,417 shares — an estimated $25.8K sold.

Citadel Advisors first reported a position in DNMR in Q2 2021 and held it in 11 quarters. The position peaked at $7.51M in Q3 2021. 3 funds tracked by Wall St. Rank hold DNMR as of Q4 2024.

  • Citadel Advisors reported no remaining Danimer Scientific, Inc. position as of Q4 2024 after selling out during the quarter.
  • Citadel Advisors sold 1,417 Danimer Scientific, Inc. shares in Q4 2024, an estimated $25.8K.
  • Citadel Advisors first reported a position in Danimer Scientific, Inc. in Q2 2021 and held it in 11 quarters.
  • Citadel Advisors's Danimer Scientific, Inc. position peaked at $7.51M in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.